B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.

[1]  M. Drazner,et al.  Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study , 2005, Circulation.

[2]  J. Potter,et al.  Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 2005, The American journal of cardiology.

[3]  D. Lloyd‐Jones,et al.  Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. , 2005, American heart journal.

[4]  E. Frohlich,et al.  Obesity and suppressed B-type natriuretic peptide levels in heart failure. , 2004, Journal of the American College of Cardiology.

[5]  W. Winter,et al.  The role and assessment of ventricular peptides in heart failure. , 2004, Clinics in laboratory medicine.

[6]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[7]  R. Sarzani,et al.  Role of the natriuretic peptide system in lipogenesis/lipolysis. , 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[8]  P. Colonna,et al.  Nonpharmacologic care of heart failure: counseling, dietary restriction, rehabilitation, treatment of sleep apnea, and ultrafiltration. , 2003, The American journal of cardiology.

[9]  S. Gottlieb,et al.  A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. , 2002, American heart journal.

[10]  D. Levy,et al.  Impact of age and sex on plasma natriuretic peptide levels in healthy adults. , 2002, The American journal of cardiology.

[11]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[12]  M. Berlan,et al.  Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women , 2002, International Journal of Obesity.

[13]  P. Krishnaswamy,et al.  A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. , 2001, Journal of cardiac failure.

[14]  M. Berlan,et al.  Natriuretic peptides: a new lipolytic pathway in human adipocytes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  D. Barnett,et al.  Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. , 1999, European heart journal.

[16]  M. Kinoshita,et al.  Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. , 1998, American heart journal.

[17]  R. Eckel,et al.  Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1997, Circulation.

[18]  M. Cohen,et al.  Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. , 1997, The American journal of cardiology.

[19]  P. Dessı̀-Fulgheri,et al.  Expression of natriuretic peptide receptors in human adipose and other tissues , 1996, Journal of endocrinological investigation.

[20]  K. Nakao,et al.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.

[21]  R. Virmani,et al.  Sudden death as a result of heart disease in morbid obesity. , 1995, American heart journal.

[22]  Michihisa Jougasaki,et al.  Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure , 1993, Circulation.

[23]  D. Goeddel,et al.  Molecular Biology of the Natriuretic Peptides and Their Receptors , 1992, Circulation.

[24]  F. Messerli,et al.  Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity. , 1987, Archives of internal medicine.

[25]  C. Porter,et al.  Plasma atrial peptide concentration during acute changes in cardiac filling pressure induced by a contrast agent , 1987, Clinical cardiology.

[26]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.